Online citations, reference lists, and bibliographies.

Oral Targeted Drug Delivery Systems: Gastric Retention Devices

Hossein Omidian, Kinam Park
Published 2010 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1016/0168-3659(96)01344-2
In vivo evaluation of a novel gastric retentive formulation based on ion exchange resins
F. Atyabi (1996)
10.1208/pt060347
Floating drug delivery systems: A review
Shweta Arora (2008)
10.1163/156856293X00140
Polyanionic hydrogel as a gastric retentive system.
Sam H. Leung (1993)
10.1016/S0168-3659(98)00066-2
A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation.
L. Yang (1999)
10.1016/S0378-5173(00)00600-1
Comparative scintigraphic assessment of the intragastric distribution and residence of cholestyramine, Carbopol 934P and sucralfate.
S. Jackson (2001)
10.1016/S0142-9612(03)00579-9
Chitosan-poly(acrylic) acid polyionic complex: in vivo study to demonstrate prolonged gastric retention.
S. Torrado (2004)
10.1080/10717540500395106
Formulation and In Vitro Characterization of Ciprofloxacin Floating and Bioadhesive Extended-Release Tablets
Jaleh Varshosaz (2006)
10.1016/j.coph.2006.04.007
Drug delivery to the upper small intestine window using gastroretentive technologies.
A. Streubel (2006)
10.1016/j.ijpharm.2006.06.002
Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique.
S. Sungthongjeen (2006)
10.1021/bk-1991-0469.ch021
Gastric Retention of Enzyme-Digestible Hydrogels in the Canine Stomach under Fasted and Fed Conditions: Preliminary Analysis Using New Analytical Techniques
Waleed S. W. Shalaby (1991)
10.1016/S0928-0987(01)00140-3
Magnetic marker monitoring of disintegrating capsules.
Werner Weitschies (2001)
10.1208/pt040451
Superporous IPN hydrogels having enhanced mechanical properties
Y. Qiu (2008)
10.1016/S0168-3659(03)00203-7
Expandable gastroretentive dosage forms.
E. Klausner (2003)
10.1016/j.ejps.2006.08.003
Compressed collagen sponges as gastroretentive dosage forms: in vitro and in vivo studies.
R. Groening (2007)
10.1248/cpb.55.580
Design and gamma-scintigraphic evaluation of a floating and pulsatile drug delivery system based on an impermeable cylinder.
H. Zou (2007)
10.1016/J.JCONREL.2007.07.011
Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pylori.
P. Rajinikanth (2008)
10.1016/S0378-5173(02)00241-7
Floating microparticles based on low density foam powder.
A. Streubel (2002)
10.1002/jbm.a.30533
Preparation and swelling behavior of chitosan-based superporous hydrogels for gastric retention application.
H. Park (2006)
A comparison of the gastric retention of a sucralfate gel and a sucralfate suspension
J. G. Hardy (1993)
10.1016/j.jconrel.2006.07.018
Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
M. Fukuda (2006)
10.1023/A:1020412817716
Novel Gastroretentive Dosage Forms: Evaluation of Gastroretentivity and Its Effect on Riboflavin Absorption in Dogs
E. Klausner (2004)
10.1016/j.ijpharm.2005.09.036
The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state.
Frances Stops (2006)
10.1016/j.ijpharm.2005.08.009
Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
M. Chavanpatil (2005)
10.1023/A:1018921830385
A Floating Controlled-Release Drug Delivery System: In Vitro-in Vivo Evaluation
Subhash Desai (1993)
10.2174/156720107782151287
Gastroretentive drug delivery system of metoclopramide hydrochloride: formulation and in vitro evaluation.
Sanjay Singh (2007)
10.1111/j.1365-2036.1994.tb00320.x
Scintigraphic assessment of the intragastric distribution and gastric emptying of an encapsulated drug: the effect of feeding and of a proton pump inhibitor.
John Christopher Atherton (1994)
Gastrointestinal absorption of drugs.
Kararli Tt (1989)
10.1615/CritRevTherDrugCarrierSyst.v19.i6.20
Floating dosage systems in drug delivery.
L. Reddy (2002)
10.1016/j.ijpharm.2006.02.001
Low density multiparticulate system for pulsatile release of meloxicam.
S. Sharma (2006)
10.1016/j.jconrel.2007.02.012
Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy.
R. A. Ishak (2007)
10.1002/PI.2311
Preparation, characterization and preliminary calcium release study of floating sodium alginate/dextran‐based hydrogel beads: part I
Sunil Kumar Bajpai (2008)
10.1016/S0378-5173(02)00396-4
Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres.
I. El-Gibaly (2002)
10.1016/j.ijpharm.2006.02.038
Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin.
M. Chavanpatil (2006)
10.1211/jpp.59.3.0001
Recent developments in superporous hydrogels.
Hossein Omidian (2007)
10.1615/CritRevTherDrugCarrierSyst.v20.i6.30
Gastric retentive dosage forms: a review.
S. Y. E. Hou (2003)
Magnetic marker monitoring of esophageal, gastric and duodenal transit of non-disintegrating capsules.
W. Weitschies (1999)
10.1111/j.1365-2036.1993.tb00129.x
Gastric retention of sucralfate gel and suspension in upper gastrointestinal diseases.
Dino Vaira (1993)
Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib.
Javed Ali (2007)
10.1080/0265204021000058384
Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles.
A. Streubel (2003)
Gastroretentive dosage forms
A. Moes (1993)
10.1111/j.1365-2036.2005.02528.x
Omeprazole delays gastric emptying in healthy volunteers: an effect prevented by tegaserod.
G. Tougas (2005)
10.1002/1097-4636(200104)55:1<54::AID-JBM80>3.0.CO;2-Y
Effect of compression on fast swelling of poly(acrylamide-co-acrylic acid) superporous hydrogels.
Richard A. Gemeinhart (2001)
10.1016/j.ijpharm.2006.09.013
Low density porous carrier drug adsorption and release study by response surface methodology using different solvents.
P. Sher (2007)
10.1208/pt0803073
Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride
M. Gambhire (2008)
10.1016/S0378-5173(00)00567-6
Amoxycillin release from a floating dosage form based on alginates.
L. Whitehead (2000)
10.1016/j.ijpharm.2006.11.008
Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori.
P. Rajinikanth (2007)
10.1016/j.jconrel.2005.08.018
Impact of the intragastric location of extended release tablets on food interactions.
W. Weitschies (2005)
10.1016/0378-5173(91)90198-W
Evaluation of the gastric retention properties of a cross-linked polymer coated tablet versus those of a non-disintegrating tablet
George A. Agyilirah (1991)
10.1615/CritRevTherDrugCarrierSyst.v15.i3.20
Gastric retentive drug-delivery systems.
S. J. Hwang (1998)
10.1118/1.2012788
A novel magnetic method for examination of bowel motility.
Wilfried Andrä (2005)
10.1080/10837450601168680
A Critical Review of Gastric Retentive Controlled Drug Delivery
K. C. Waterman (2007)
10.1016/S0168-3659(99)00139-X
Gastric retention properties of superporous hydrogel composites.
J. Chen (2000)
10.1016/S0378-5173(98)00305-6
Effect of dose size, food and surface coating on the gastric residence and distribution of an ion exchange resin
S. Thairs (1998)
10.1615/CritRevTherDrugCarrierSyst.v23.i3.10
Oral controlled-release formulation in veterinary medicine.
Eran Lavy (2006)
10.1002/jps.2600830106
Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy.
J. Timmermans (1994)
In vitro and in vivo evaluation of floating controlled release dosage forms of verapamil hydrochloride
S. Elkheshen (2004)
10.1002/app.26456
Preparation and evaluation of cellulose acetate butyrate and poly(ethylene oxide) blend microspheres for gastroretentive floating delivery of repaglinide
A. P. Rokhade (2007)
10.1080/10717540260397837
Floating-Bioadhesive Microspheres Containing Acetohydroxamic Acid for Clearance of Helicobacter Pylori
R. Umamaheswari (2002)
10.1080/02580144.1977.10429246
A new look at central city-suburban differences
John J. Harrigan (1977)
10.1016/S0378-5173(98)00230-0
Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation
V. Iannuccelli (1998)
10.1016/S0928-0987(03)00121-0
Evaluation of microcrystalline chitosans for gastro-retentive drug delivery.
M. Säkkinen (2003)
10.1016/S1773-2247(06)50064-4
In vitro and in vivo evaluation in healthy human volunteers of floating riboflavin minitablets
Jonathan Goole (2006)
10.1081/DMR-100104401
MICROSPHERES AS FLOATING DRUG-DELIVERY SYSTEMS TO INCREASE GASTRIC RETENTION OF DRUGS
K. Soppimath (2001)
10.1016/j.addr.2005.01.025
Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms.
W. Weitschies (2005)
10.1016/S0939-6411(01)00178-3
Determination of the disintegration behavior of magnetically marked tablets.
W. Weitschies (2001)
10.1016/0378-5173(93)90029-F
Gastrointestinal transit of a matrix tablet formulation: comparison of canine and human data
S. Davis (1993)
10.1016/S0168-3659(99)00204-7
Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention.
B. Singh (2000)
10.1016/j.ijpharm.2005.09.039
Citric acid prolongs the gastro-retention of a floating dosage form and increases bioavailability of riboflavin in the fasted state.
Frances Stops (2006)
10.1016/j.ijpharm.2006.05.056
In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process.
Jamila Hamdani (2006)
10.1016/S0939-6411(98)00052-6
Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit.
R. Groening (1998)
10.1016/S1773-2247(07)50051-1
Development of a multi-unit floating drug delivery system by hot melt coating technique with drug-lipid dispersion
K. Chansanroj (2007)
10.1016/S0168-3659(98)00154-0
Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy.
F. Kedzierewicz (1999)
10.1016/S1359-6446(04)03351-3
Formulation strategies for absorption windows.
S. Davis (2005)
10.1007/s11095-006-9189-9
A Novel Method to Radiolabel Gastric Retentive Formulations for Gamma Scintigraphy Assessment
Matthew D Burke (2006)
10.1016/S1773-2247(07)50019-5
Design and evaluation of a floating ranitidine tablet as a drug delivery system for oral application
Mohammad A. Hassan (2007)
10.1016/j.jconrel.2006.03.022
Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans.
L. Kagan (2006)
10.1081/DDC-200040239
Gastroretentive Delivery Systems: A Mini Review
R. Talukder (2004)
10.1080/713840399
A New Approach in Gastroretentive Drug Delivery System Using Cholestyramine
R. Umamaheshwari (2003)
10.1016/j.jconrel.2004.09.028
Advances in superporous hydrogels.
Hossein Omidian (2005)
Design and evaluation of bilayer floating tablets of cefuroxime axetil for bimodal release
Ravindra Sunil Dhumal (2006)
10.1016/j.jconrel.2005.10.031
Gastroretentive dosage forms: overview and special case of Helicobacter pylori.
P. Bardonnet (2006)
10.1016/0168-3659(96)01343-0
Controlled drug release from coated floating ion exchange resin beads
F. Atyabi (1996)
10.1023/A:1025770530084
Novel Gastroretentive Dosage Forms: Evaluation of Gastroretentivity and Its Effect on Levodopa Absorption in Humans
E. Klausner (2004)
10.1088/0031-9155/45/10/322
A novel method for real-time magnetic marker monitoring in the gastrointestinal tract.
W. Andrä (2000)
10.1515/bmte.2002.47.s1b.506
INVESTIGATION OF GASTROINTESTINAL TRANSPORT BY MAGNETIC MARKER LOCALIZATION
Olaf Kosch (2002)
10.1088/1126-6708/2002/09/036
First order gauge field theories from a superfield formulation
Ludde Edgren (2002)
10.2174/156720107779314730
Formulation and evaluation of famotidine floating tablets.
M. Jaimini (2007)
10.1016/J.EJPB.2007.06.017
New levodopa sustained-release floating minitablets coated with insoluble acrylic polymer.
J. Goole (2008)
10.2174/1381612053381819
Drug delivery strategies for the treatment of Helicobacter pylori infections.
B. Conway (2005)
10.1016/S0168-3659(02)00487-X
Novel levodopa gastroretentive dosage form: in-vivo evaluation in dogs.
E. Klausner (2003)
10.1358/mf.2006.28.7.1003574
Formulation and development of gastroretentive drug delivery system for ofloxacin.
Javed Ali (2006)
10.1016/0378-5173(94)90455-3
A comparison of the gastric retention of alginate containing tablet formulations with and without the inclusion of excipient calcium ions
Nigel Davies (1994)
10.1002/mabi.200600062
Elastic, superporous hydrogel hybrids of polyacrylamide and sodium alginate.
Hossein Omidian (2006)
10.1016/S0168-3659(97)00266-6
Floating dosage forms: an in vivo study demonstrating prolonged gastric retention.
L. Whitehead (1998)
10.1208/pt070234
Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention
C. Narendra (2008)
10.1016/j.ijpharm.2006.09.021
Bioavailability of riboflavin from a gastric retention formulation.
I. S. Ahmed (2007)
10.1016/j.ijpharm.2006.11.060
Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form.
Yong-dan Tang (2007)
10.1088/1126-6708/2004/01/006
Superfield algorithm for higher order gauge field theories
Ludde Edgren (2004)
10.1016/S0378-5173(02)00054-6
Preparation of alginate beads for floating drug delivery system: effects of CO(2) gas-forming agents.
B. Y. Choi (2002)
10.1081/DDC-200037179
The Macromolecular Polymers for the Preparation of Hydrodynamically Balanced Systems—Methods of Evaluation
P. Dorożyński (2004)
10.1177/088391102030910
Experimental Design for the Synthesis of Polyacrylamide Superporous Hydrogels
Hossein Omidian (2002)
10.1208/pt050234
Gastroretentive drug delivery system of ranitidine hydrochloride: Formulation and in vitro evaluation
B. S. Dave (2008)
10.1016/j.ijpharm.2003.09.047
Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms.
A. Hoffman (2004)
10.1016/0142-9612(92)90052-P
Use of ultrasound imaging and fluoroscopic imaging to study gastric retention of enzyme-digestible hydrogels.
W. S. Shalaby (1992)
10.1212/WNL.46.4.1051
Gastric emptying in Parkinson's disease
R. Djaldetti (1996)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar